Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 126, Issue 5, Pages 679-704
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-02-28
DOI
10.1161/circresaha.119.316337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
- (2020) Silvia Sookoian et al. GUT
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
- (2019) Jingjing Cai et al. HEPATOLOGY
- NIK as a Druggable Mediator of Tissue Injury
- (2019) Lara Valiño-Rivas et al. TRENDS IN MOLECULAR MEDICINE
- Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT
- (2019) Tomas Vita et al. RADIOLOGY
- The degree of hepatic steatosis associates with impaired cardiac and autonomic function
- (2019) David Houghton et al. JOURNAL OF HEPATOLOGY
- Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume
- (2019) Robin D. Abeles et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-Alcoholic Fatty Liver Disease is Associated with Arterial Distensibility and Carotid Intima Media Thickness: (From the Multi-Ethnic Study of Atherosclerosis [MESA]).
- (2019) Ebenezer Oni et al. AMERICAN JOURNAL OF CARDIOLOGY
- Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk: A Cross-Sectional Study
- (2019) Alexander Kurilshikov et al. CIRCULATION RESEARCH
- Intestinal Microbiota in Cardiovascular Health and Disease
- (2019) W.H. Wilson Tang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The association between liver fat and systemic calcified atherosclerosis
- (2019) Bo Kyung Koo et al. JOURNAL OF VASCULAR SURGERY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis
- (2019) Anna E. Bortnick et al. ATHEROSCLEROSIS
- Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
- (2019) Daniel Margerie et al. BMC Medical Genomics
- Structure and function of angiopoietin-like protein 3 (ANGPTL3) in atherosclerosis
- (2019) Xinjie Lu CURRENT MEDICINAL CHEMISTRY
- The 2018 ESC/ESH Guidelines for the management of arterial hypertension: A German point of view
- (2019) Insa E Emrich et al. EUROPEAN HEART JOURNAL
- Hepatocyte TRAF6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lys6- Linked Polyubiquitination of ASK1
- (2019) Yutao Wang et al. HEPATOLOGY
- NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
- (2019) Amedeo Lonardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors
- (2019) Donna K. Arnett et al. JAMA Cardiology
- Promising Directions in Atherosclerosis Treatment Based on Epigenetic Regulation Using MicroRNAs and Long Noncoding RNAs
- (2019) Daria Skuratovskaia et al. Biomolecules
- Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
- (2019) Kwok Leung Ong et al. ATHEROSCLEROSIS
- Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
- (2019) Christian Anholm et al. ATHEROSCLEROSIS
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
- (2019) Leanne Hodson et al. Nature Reviews Endocrinology
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- From circadian clocks to non-alcoholic fatty liver disease
- (2019) Yu Ji et al. Expert Review of Gastroenterology & Hepatology
- Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
- (2019) Ze Chen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis
- (2018) B. Hameed et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
- (2018) Jilin Zheng et al. BMC Cardiovascular Disorders
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Nonalcoholic fatty liver disease and hypertension
- (2018) Dimitrios Oikonomou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study
- (2018) Seung Bum Lee et al. JOURNAL OF HEPATOLOGY
- Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients
- (2018) Yong-ho Lee et al. JOURNAL OF HEPATOLOGY
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
- (2018) Chun-Ming Wong et al. Nature Reviews Gastroenterology & Hepatology
- Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men
- (2018) Jung Eun Lee et al. PLoS One
- IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
- (2018) Andreea-Manuela Mirea et al. TRENDS IN MOLECULAR MEDICINE
- Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
- (2018) Jingjing Cai et al. Annual Review of Pathology-Mechanisms of Disease
- Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis
- (2018) Karn Wijarnpreecha et al. DIGESTIVE AND LIVER DISEASE
- Mitochondrial calcium transport and the redox nature of the calcium-induced membrane permeability transition
- (2018) Anibal E. Vercesi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks
- (2018) Eun Ky Kim et al. DIABETES CARE
- Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women
- (2018) Zeneng Wang et al. EUROPEAN HEART JOURNAL
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study
- (2018) Yoosoo Chang et al. GUT
- Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter
- (2018) Hyo Eun Park et al. JOURNAL OF GASTROENTEROLOGY
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy‐proven Nonalcoholic Steatohepatitis
- (2018) Maureen Whitsett et al. LIVER INTERNATIONAL
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
- (2018) Meng Xu et al. PHYSIOLOGICAL REVIEWS
- Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance
- (2018) Justin McNair Canada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
- (2017) Bo Kobberø Lauridsen et al. EUROPEAN HEART JOURNAL
- The association of nonalcoholic steatohepatitis and obstructive sleep apnea
- (2017) Mohammad M. Asfari et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study
- (2017) Sharon S. Brouha et al. EUROPEAN RADIOLOGY
- PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease
- (2017) Nynke Simons et al. GASTROENTEROLOGY
- The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
- (2017) Feng-Juan Yan et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Reprogramming Innate Immune Signaling in Cardiometabolic Disease
- (2017) Yaxing Zhang et al. HYPERTENSION
- Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E–Deficient MiceNovelty and Significance
- (2017) Hui Liu et al. HYPERTENSION
- Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet
- (2017) Jia Zeng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
- (2017) Mukul R. Jain et al. LIVER INTERNATIONAL
- The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome
- (2017) Kyoung Im Cho et al. Metabolic Syndrome and Related Disorders
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis
- (2017) Karn Wijarnpreecha et al. Clinics and Research in Hepatology and Gastroenterology
- Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study
- (2017) Michelle T. Long et al. Journal of the American Heart Association
- Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population
- (2017) Ren-Nan Feng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance
- (2016) Pengcheng Luo et al. AMERICAN JOURNAL OF PATHOLOGY
- Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
- (2016) Rainey E. Patterson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Facilitatory effects of fetuin-A on atherosclerosis
- (2016) Chisato Naito et al. ATHEROSCLEROSIS
- Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes
- (2016) Arata Fukushima et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?
- (2016) Peter Willeit et al. EUROPEAN HEART JOURNAL
- A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients
- (2016) Ahmed Abdel-Razik et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
- (2016) Petra Hirsova et al. GASTROENTEROLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
- (2016) Dong Hyun Sinn et al. GASTROENTEROLOGY
- Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
- (2016) Timothy Hardy et al. GUT
- Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study
- (2016) Jari E. Kaikkonen et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Emerging role of exosomes in liver physiology and pathology
- (2016) Shuangpeng Cai et al. HEPATOLOGY RESEARCH
- Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study
- (2016) Byung Jin Kim et al. Journal of Clinical Lipidology
- DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
- (2016) Lanfeng Xie et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Preserved hemostatic status in patients with non-alcoholic fatty liver disease
- (2016) Wilma Potze et al. JOURNAL OF HEPATOLOGY
- Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
- (2016) J. Jager et al. JOURNAL OF INTERNAL MEDICINE
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation
- (2016) Charlotte Thålin et al. THROMBOSIS RESEARCH
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
- (2016) Yan-Xiao Ji et al. Nature Communications
- Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population
- (2016) Chengfu Xu et al. Scientific Reports
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice
- (2016) Jie Yu et al. Scientific Reports
- Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- (2015) Ayse Emre et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control
- (2015) Sophie Cassidy et al. Cardiovascular Diabetology
- Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
- (2015) Z. Lin et al. CIRCULATION
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
- (2015) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study
- (2015) Lisa B. VanWagner et al. HEPATOLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease
- (2015) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis
- (2015) Jonathan G. Stine et al. LIVER TRANSPLANTATION
- Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
- (2015) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells
- (2015) Hwan-Jin Hwang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
- (2015) Alice Conigliaro et al. Molecular Cancer
- Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2015) Wilma Potze et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease
- (2015) Andrea A Baccarelli et al. Clinical Epigenetics
- Metabolic syndrome: a sympathetic disease?
- (2015) Markus Schlaich et al. Lancet Diabetes & Endocrinology
- A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study
- (2015) Ji Hye Huh et al. PLoS One
- Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort
- (2014) Alvaro Alonso et al. HEART
- Clinical association between non-alcoholic fatty liver disease and the development of hypertension
- (2014) Jae-Hong Ryoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2014) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
- (2014) Ki-Chul Sung et al. JOURNAL OF HEPATOLOGY
- Clinical Significance of Non-Alcoholic Fatty Liver Disease as a Risk Factor for Prehypertension
- (2014) Jae-Hong Ryoo et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases
- (2014) Yonggang Wang et al. Oxidative Medicine and Cellular Longevity
- Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
- (2014) Stefano Bonapace et al. PLoS One
- Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
- (2014) Joo Lee et al. Nutrients
- Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population
- (2013) Marcello Ricardo Paulista Markus et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State
- (2013) Julian I. Borissoff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease
- (2013) Oktay Bilgir et al. BLOOD COAGULATION & FIBRINOLYSIS
- Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study
- (2013) Gonenc Kocabay et al. CLINICAL SCIENCE
- A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
- (2013) Rajendrakumar H. Jani et al. Diabetes Technology & Therapeutics
- Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance
- (2013) Xin-An Wang et al. HEPATOLOGY
- Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket
- (2013) Shih-Chia Tso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Levels of the Oxidative Stress Marker γ-Glutamyltranspeptidase at Different Stages of Nonalcoholic Fatty Liver Disease
- (2013) M Irie et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Relationship of Serum Fetuin-A Levels with Coronary Atherosclerotic Burden and NAFLD in Patients Undergoing Elective Coronary Angiography
- (2013) Stefano Ballestri et al. Metabolic Syndrome and Related Disorders
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability
- (2013) Yu-Chen Liu et al. PLoS One
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
- (2012) Moritz F. Sinner et al. AMERICAN JOURNAL OF CARDIOLOGY
- Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians
- (2012) Manik Lal Thakur et al. ATHEROSCLEROSIS
- Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: The Shanghai Changfeng study
- (2012) Xiaoming Li et al. ATHEROSCLEROSIS
- Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study
- (2012) Lauren N. Bell et al. HEPATOLOGY
- Fatty liver index, gamma-glutamyltransferase, and early carotid plaques
- (2012) Michaela Kozakova et al. HEPATOLOGY
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
- (2012) Zheng Sun et al. NATURE MEDICINE
- Complement C3 and cleavage products in cardiometabolic risk
- (2011) Altan Onat et al. CLINICA CHIMICA ACTA
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2
- (2011) G. Tolhurst et al. DIABETES
- Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis
- (2011) Naim Alkhouri et al. HEPATOLOGY
- Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis
- (2011) S. J. Yang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism
- (2011) D. Feng et al. SCIENCE
- Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
- (2010) Sérgio Henrique S. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes
- (2010) Sandhya Narasimhan et al. CLINICAL BIOCHEMISTRY
- Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor-β–Activated Kinase 1–Dependent Signaling
- (2010) He Huang et al. HYPERTENSION
- Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
- (2010) Julien Bricambert et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
- (2010) Luuk J. Rijzewijk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
- (2010) Anna Kotronen et al. LIVER INTERNATIONAL
- Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
- (2010) Kohichiroh Yasui et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
- (2009) Silvia Sookoian et al. ATHEROSCLEROSIS
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
- (2009) Masaru Iwai et al. HYPERTENSION RESEARCH
- Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease
- (2009) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
- (2008) B. S. Samuel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS)
- (2006) Soo Lim et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started